In the article by Friberg et al, “Response to Letter Regarding Article, ‘Net Clinical Benefit of Warfarin in Patients With Atrial Fibrillation: A Report From the Swedish Atrial Fibrillation Cohort Study’,” which published in the November 13, 2012 issue of the journal (Circulation. 2012;126:e323), there was an error in the last sentence of the second paragraph. The sentence should read:
“The CHADS2 score is not the way to define low risk because the stroke rate in patients with a CHADS2 score of 0 can range from 0.8%/y to 3.2%/y.2.”
The current online version of the manuscript has been corrected.
- © 2012 American Heart Association, Inc.